ResearcherNew York UniversityActive in the last 2 years

Xiaofei Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-3715-9256; OpenAlex author ID A5115591808. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 6

Papers, trials and grants by year

2025: 1 paper

Papers 1

Complement activation in tumor microenvironment after neoadjuvant therapy and its impact on pancreatic cancer outcomes. Co-author DOI 10.1038/s41698-025-00848-2 ↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Danting Li · 1 shared paper, 2025 · strength 0.21
- Paper Complement activation in tumor microenvironment after neoadjuvant therapy and its impact on pancreatic cancer outcomes. DOI 10.1038/s41698-025-00848-2 ↗
Venu Gopal Pillarisetty · 1 shared paper, 2025 · strength 0.21
- Paper Complement activation in tumor microenvironment after neoadjuvant therapy and its impact on pancreatic cancer outcomes. DOI 10.1038/s41698-025-00848-2 ↗
Yaozhong Liu · 1 shared paper, 2025 · strength 0.21
- Paper Complement activation in tumor microenvironment after neoadjuvant therapy and its impact on pancreatic cancer outcomes. DOI 10.1038/s41698-025-00848-2 ↗
Michael Shusterman · 1 shared paper, 2025 · strength 0.21
- Paper Complement activation in tumor microenvironment after neoadjuvant therapy and its impact on pancreatic cancer outcomes. DOI 10.1038/s41698-025-00848-2 ↗
Jessica L. Widmer · 1 shared paper, 2025 · strength 0.21
- Paper Complement activation in tumor microenvironment after neoadjuvant therapy and its impact on pancreatic cancer outcomes. DOI 10.1038/s41698-025-00848-2 ↗
John Allendorf · 1 shared paper, 2025 · strength 0.21
- Paper Complement activation in tumor microenvironment after neoadjuvant therapy and its impact on pancreatic cancer outcomes. DOI 10.1038/s41698-025-00848-2 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.